Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2026-01-01 @ 12:58 AM
Study NCT ID:
NCT01107535
Status:
COMPLETED
Last Update Posted:
2012-10-31
First Post:
2010-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection
Sponsor:
Abbott
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09
Start Date Type:
None
Primary Completion Date:
2011-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-20
First Submit QC Date:
None
Study First Post Date:
2010-04-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-02-07
Results First Submit QC Date:
None
Results First Post Date:
2012-04-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-10-26
Last Update Post Date:
2012-10-31
Last Update Post Date Type:
ESTIMATED